Search research articles
Contact Us
Filters
Showing results (71-80 of 107) with videos related to
Page
of 11
Sort By:
Cancer Research
|
July 12, 2011
CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer
Elda Righi, Satoshi Kashiwagi, Jianping Yuan, et al.
Plos One
|
April 13, 2011
R5-SHIV induces multiple defects in T cell function during early infection of rhesus macaques including accumulation of T reg cells in lymph nodes
Michael Santosuosso, Elda Righi, E David Hill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2021
Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
Binghao Li, Guoqi Li, Xiaobo Yan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 18, 2024
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
Alex L Roederer, Yi Cao, Kerri St Denis, et al.
Cell Reports. Medicine
|
December 10, 2024
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
Alex L Roederer, Yi Cao, Kerri St Denis, et al.
Cancer Immunology Research
|
March 8, 2018
AMD3100 Augments the Efficacy of Mesothelin-Targeted, Immune-Activating VIC-008 in Mesothelioma by Modulating Intratumoral Immunosuppression
Binghao Li, Yang Zeng, Patrick M Reeves, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 10, 2012
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
Yuhui Huang, Jianping Yuan, Elda Righi, et al.
Plos One
|
July 27, 2010
R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models
Nagadenahalli B Siddappa, Jennifer D Watkins, Klemens J Wassermann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 27, 2025
Immune Composition and Immunotherapy Outcomes of Mesothelioma With BAP1, CDKN2A, MTAP, and NF2 Alterations
Ibiayi Dagogo-Jack, Owen Mitchell, Elizabeth Codd, et al.
Frontiers in Immunology
|
March 5, 2019
Promiscuous <i>Coxiella burnetii</i> CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine
Anja Scholzen, Guilhem Richard, Leonard Moise, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 107) with videos related to
Sort By:
Page
of 11
Cancer Research
|
July 12, 2011
CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer
Elda Righi, Satoshi Kashiwagi, Jianping Yuan, et al.
Plos One
|
April 13, 2011
R5-SHIV induces multiple defects in T cell function during early infection of rhesus macaques including accumulation of T reg cells in lymph nodes
Michael Santosuosso, Elda Righi, E David Hill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2021
Fresh Tissue Multi-omics Profiling Reveals Immune Classification and Suggests Immunotherapy Candidates for Conventional Chondrosarcoma
Binghao Li, Guoqi Li, Xiaobo Yan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 18, 2024
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
Alex L Roederer, Yi Cao, Kerri St Denis, et al.
Cell Reports. Medicine
|
December 10, 2024
Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity
Alex L Roederer, Yi Cao, Kerri St Denis, et al.
Cancer Immunology Research
|
March 8, 2018
AMD3100 Augments the Efficacy of Mesothelin-Targeted, Immune-Activating VIC-008 in Mesothelioma by Modulating Intratumoral Immunosuppression
Binghao Li, Yang Zeng, Patrick M Reeves, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 10, 2012
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
Yuhui Huang, Jianping Yuan, Elda Righi, et al.
Plos One
|
July 27, 2010
R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models
Nagadenahalli B Siddappa, Jennifer D Watkins, Klemens J Wassermann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 27, 2025
Immune Composition and Immunotherapy Outcomes of Mesothelioma With BAP1, CDKN2A, MTAP, and NF2 Alterations
Ibiayi Dagogo-Jack, Owen Mitchell, Elizabeth Codd, et al.
Frontiers in Immunology
|
March 5, 2019
Promiscuous <i>Coxiella burnetii</i> CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine
Anja Scholzen, Guilhem Richard, Leonard Moise, et al.
Page
of 11